Prothena Corporation PLC (NASDAQ:PRTA)

During the Trading Day
18.80 +1.01 / +5.68%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
18.80 0.00 / 0.00%
 
Volume: 4.2K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$474.2M

Company Description

Prothena Corp. Plc is a clinical stage biotechnology company, which focuses on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion. It focuses on therapeutic monoclonal antibodies directed specifically to disease causing proteins. The company's antibody-based product candidates target a number of potential indications including AL and AA forms of amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002) and novel cell adhesion targets involved in inflammatory diseases and cancers (PRX003). Prothena was founded on September 26, 2012 and is headquartered in Dublin, Ireland.

Contact Information

Prothena Corp. Plc
Alexandra House
Dublin Dublin 4
P:(531) 902-3519
Investor Relations:
(650) 837-8535

Employees

Shareholders

Other institutional39.24%
Mutual fund holders38.03%
Individual stakeholders12.02%

Top Executives

Dale B. SchenkPresident, Chief Executive Officer & Director
Tran B. NguyenChief Financial Officer & Head-Investor Relations
Gene G. KinneyCSO & Head-Research & Development
Martin KollerChief Medical Officer
Karin L. WalkerChief Accounting Officer & Controller

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.